Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.
ACS medicinal chemistry letters • Vol. 6, Issue 12 • 2015
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences • Vol. 52 • 2014
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
The Proceedings of the Nutrition Society • Vol. 73, Issue 1 • 2014
Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategies.
International review of psychiatry (Abingdon, England) • Vol. 21, Issue 2 • 2009